Lipid News

Transport of O-palmitoleated Wnts: Where does the lipid go?

Rie Nygaard Filippo Mancia
By Rie Nygaard and Filippo Mancia
Feb. 16, 2021

Wnts are evolutionarily conserved ligands that signal at short range to regulate morphogenesis, cell fate and stem cell renewal. The first and essential step in Wnts' secretion is their O-palmitoleation by the enzyme porcupine, or PORCN. This lipid modification is unique to Wnts and crucial for limiting their diffusion, restricting Wnt signaling to short range.

Lipid-news-445x561.jpg
Rie Nygaard & Filippo Mancia
The structure of human O-palmitoleated WNT8A (green) in complex with its dedicated carrier WLS (blue). The O-palmitoleate is shown as yellow spheres, and the main structural elements are labeled.

Modification of Wnts has been shown to be essential to their signaling capabilities. After their O-palmitoleation in the endoplasmic reticulum, or ER, Wnts are loaded onto their dedicated transporter Wntless, or WLS, an integral membrane protein with a small soluble domain in the ER lumen. O-palmitoleated Wnts associated with WLS then travel to the plasma membrane, where they are transferred to receptors, such as Frizzled, on the membranes of target cells, in turn triggering the activation of signaling pathways. Structures of Wnt in complex with the cysteine-rich domain, or CRD, of Frizzled have shown how the lipid modification of Wnt is central to binding, with the O-palmitoleate buried deep in a hydrophobic groove of the CRD.

Questions remained about Wnts' transfer from the ER to target cells and the role of the O-palmitoleate: How does the transfer of the O-palmitoleated Wnt from PORCN to WLS occur? Where does the O-palmitoleate reside when Wnts are in complex with WLS, within the protein or in the membrane? How are Wnts released from WLS, and how do they travel with their water-insoluble cargo to neighboring cells?

We recently reported the structure of human O-palmitoleated WNT8A in complex with WLS, determined by single-particle cryo-electron microscopy to 3.2 Å resolution. The structure shows that the WLS membrane domain has close structural homology to G protein–coupled receptors, or GPCRs, with the addition of a transmembrane helix connecting the N-terminus to its luminal domain.

Based on the structures of Wnt bound to the CRD domain of Frizzled, we expected that the O-palmitoleate would be inserted into a hydrophobic binding site within the luminal domain of WLS. Instead, the Wnt hairpin carrying the lipid as a covalent attachment inserts deeply into a conserved hydrophobic cavity in the GPCR-like domain with the O-palmitoleate protruding between two transmembrane helices into the lipid bilayer.

We observed an extensive binding surface between Wnt and WLS, consistent with the known tight interaction between the two, while the energetically favorable environment of the membrane sheltered the hydrophobic cargo. A large opening to the bilayer within the membrane domain of WLS might be the route for shuttling the O-palmitoleate from PORCN to WLS, maintaining the lipid within the bilayer during the transfer and possibly involving a direct interaction between the enzyme and the carrier.

Comparing the structure of Wnt in complex with WLS to the structures of Wnt bound to the CRD domain of Frizzled, we observed a large conformational change on a separate Wnt hairpin, which may be important for its one-way transfer to receiving cells. For this transfer to occur, the O-palmitoleate must be extracted from the lipid bilayer and transferred to the CRD domain of Frizzled.

It's unclear if and when this involves other proteins and whether the transfer occurs in cis (the same) or trans (the opposite) membranes.

This work provides molecular-level insights into a central mechanism in animal body plan development and stem cell biology. We believe it opens up a new direction to explore membrane protein–lipid interactions.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition weekly.

Learn more
Rie Nygaard
Rie Nygaard

Rie Nygaard is an associate research scientist in Filippo Mancia’s lab in the department of physiology and cellular biophysics at Columbia University Irving Medical Center.

Filippo Mancia
Filippo Mancia

Filippo Mancia is an associate professor and co-director of graduate education in the department of physiology and cellular biophysics at Columbia University Irving Medical Center.

Related articles

Cholesterol lures in coronavirus
Marissa Locke Rottinghaus
A surprising modification lowers the lipid binding affinity of a membrane trafficking protein
Jefferson Knight, Colin T. Shearn & Cisloynny Beauchamp–Pérez
Tour de flippase
Todd R. Graham
Proteins and lipids — a complicated relationship?
Eva Sevcsik & Gerhard J. Schütz

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Transforming learning through innovation and collaboration
Award

Transforming learning through innovation and collaboration

Nov. 22, 2024

Neena Grover will receive the William C. Rose Award for Exemplary Contributions to Education at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.

Guiding grocery carts to shape healthy habits
Award

Guiding grocery carts to shape healthy habits

Nov. 21, 2024

Robert “Nate” Helsley will receive the Walter A. Shaw Young Investigator in Lipid Research Award at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.

Quantifying how proteins in microbe and host interact
Journal News

Quantifying how proteins in microbe and host interact

Nov. 20, 2024

“To develop better vaccines, we need new methods and a better understanding of the antibody responses that develop in immune individuals,” author Johan Malmström said.

Leading the charge for gender equity
Award

Leading the charge for gender equity

Nov. 19, 2024

Nicole Woitowich will receive the ASBMB Emerging Leadership Award at the 2025 ASBMB Annual meeting, April 12–15 in Chicago.

CRISPR gene editing: Moving closer to home
News

CRISPR gene editing: Moving closer to home

Nov. 17, 2024

With the first medical therapy approved, there’s a lot going on in the genome editing field, including the discovery of CRISPR-like DNA-snippers called Fanzors in an odd menagerie of eukaryotic critters.

Finding a missing piece for neurodegenerative disease research
News

Finding a missing piece for neurodegenerative disease research

Nov. 16, 2024

Ursula Jakob and a team at the University of Michigan have found that the molecule polyphosphate could be what scientists call the “mystery density” inside fibrils associated with Alzheimer’s, Parkinson’s and related conditions.